Detalhe da pesquisa
1.
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors.
Cell
; 176(3): 505-519.e22, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30612738
2.
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.
Cell
; 162(1): 146-59, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140595
3.
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Blood
; 143(6): 522-534, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946299
4.
Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response.
Nat Rev Mol Cell Biol
; 14(9): 563-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23969844
5.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging
; 51(5): 1361-1370, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114616
6.
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.
Eur J Haematol
; 112(6): 957-963, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369814
7.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Am J Hematol
; 99(2): 203-215, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009469
8.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
9.
Cytokine-induced signaling networks prioritize dynamic range over signal strength.
Cell
; 135(2): 343-54, 2008 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957207
10.
Biallelic variants in YRDC cause a developmental disorder with progeroid features.
Hum Genet
; 140(12): 1679-1693, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545459
11.
DNA damage pathways and B-cell lymphomagenesis.
Curr Opin Hematol
; 25(4): 315-322, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29702521
12.
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.
Cancer Immunol Immunother
; 67(11): 1797-1807, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203262
13.
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Blood
; 127(22): 2732-41, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27048211
14.
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization.
Mol Cell
; 40(1): 34-49, 2010 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20932473
15.
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Trends Genet
; 30(8): 326-39, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25017190
16.
The combined status of ATM and p53 link tumor development with therapeutic response.
Genes Dev
; 23(16): 1895-909, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608766
17.
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.
EMBO J
; 31(20): 3961-75, 2012 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909821
18.
The p53 network: cellular and systemic DNA damage responses in aging and cancer.
Trends Genet
; 28(3): 128-36, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265392
19.
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
Cancer Cell
; 11(2): 175-89, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17292828
20.
The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.
Hum Mol Genet
; 21(26): 5528-38, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23026745